Company Overview and News

32
USO MACD Bearish Cross, But Uptrend Still Intact

1h seekingalpha
USO is up significantly for the year due to robust demand coming from overseas, and long cycle investing being replaced by shorter cycle investing which creates large supply deficits.
APC ETP.PRC MPLX CKRGZ USO XOM CHKVP CTLR CHKDH CHKVZ HCLP CHKDG CHKWZ CHKDJ ETP CHKDP CHK CHK.WI CLR CHK.PRD AEUA

30
Reis & Irvy's Robot-Staffed Frozen Yogurt Chain Inks $9.6 Million Master Franchise Agreements in Columbus, Ohio and Oklahoma City

2018-07-17 globenewswire
Columbus and Oklahoma City are the latest expansion territories that also include Miami, Orange County, Los Angeles and Atlanta San Diego, CA, July 17, 2018 (GLOBE NEWSWIRE) -- Generation NEXT Franchise Brands, Inc. (OTCQB: VEND) announced today that its flagship subsidiary, Reis & Irvy’s, has signed two agreements with exclusive master franchise rights for the robot-staffed frozen yogurt chain in both Ohio and Oklahoma.
REIS CKRGZ CHKVP DVN CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK.WI BOE CHK CHK.PRD BA

115
3 Big Stock Charts for Tuesday: Sealed Air, Eastman Chemical and Walt Disney | InvestorPlace

2018-07-17 investorplace
The market didn’t start the new trading week nearly as bullishly as it ended the previous one. When all was said and done, the S&P 500 ended the day a tad in the red, led lower by no stock in particular. The most noteworthy losers were Ford Motor (NYSE:F) and Chesapeake Energy (NYSE:CHK), which are noteworthy names, but not exactly heavy hitters.
SEE CKRGZ F CHKVP AMD NYTAB CHKDH CHKVZ CHKDG CHKWZ BAC EMN.WS CHKDJ CHKDP CHK EMN CHK.WI CHK.PRD DIS

29
Cramer's lightning round: The best way to add gold to your portfolio

2018-07-16 cnbc
Barrick Gold Corporation: “Look, I always think people should have some gold. I like the Gold, GLD, or I like gold, the bullion. It is really hard to own the stocks. Barrick? Sell, sell, sell.”
CKRGZ ABX CHKVP ZBRA CHKDH CHKVZ CHKDG CHKWZ CHKDJ DVAX CHKDP CHK.WI CHK CHK.PRD ABX

43
Natural Gas Falls Despite Bullish Inventory Data: Here's Why

2018-07-16 zacks
The U.S. Energy Department's weekly inventory release showed a smaller-than-expected increase in natural gas supplies. Despite the headline beat, bearish weather predictions pointed to weakening demand and pressured the fuel’s price, which lost around 4% for the week.
ECR CKRGZ POOL CQP LNG CHKVP CRK COG CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP GTT CHK CHK.WI CHK.PRD

29
Chesapeake Energy Corp.: Significant Surprise Potential

2018-07-16 seekingalpha
Chesapeake Energy has considerable surprise potential heading into earnings, as price realizations have continued to rebound in Q2.
CHKDJ CKRGZ CHKDP CHK CHKVP CHK.WI CHKDH CHKVZ CHK.PRD CHKDG CHKWZ

29
Sanchez Energy Profit Progress

2018-07-15 seekingalpha
A large $2.3 billion acquisition like Comanche often takes a few years to optimize results. The previous large acquisition, Catarina, took a few years.
SN APC CKRGZ CHKVP BGFLX SCAZP LNR CHKDH CHKVZ CHKDG EOG CHKWZ CHKDJ CHKDP CHK.WI CHK CHK.PRD SNZYP AEUA

164
The 5 Most Shorted NYSE Stocks

2018-07-12 247wallst
Did investors sell in May and go away, even in the face of increasing fears of trade wars with China and U.S. allies, not to mention the specter of rising interest rates? The Nasdaq, the Dow Jones industrial average and the S&P 500 did all lose some ground last month, as there were few earnings reports to help buoy them. That will soon change, for better or worse.
CKRGZ CHKVP RAD DTK CHKDH CHKVZ CHKDG CHKWZ CHKDJ NDAQ CHKDP CHK CHK.WI CHK.PRD

44
Oakmark Select Fund: Second Quarter 2018

2018-07-11 seekingalpha
For the quarter, the Oakmark Select Fund declined 0.4%, compared to a 3.4% increase in the S&P 500 Index, the Fund’s benchmark. Year to date, the Fund declined 4.3%, compared to a 2.7% increase for the S&P 500.
MGM REGN CKRGZ APA AAL ADNT CHKVP HOG CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI WFT CHK.PRD

29
Chesapeake Energy May Have A Second Big Oil Discovery

2018-07-10 seekingalpha
Chesapeake Energy has a free cash flow engine in their big oil discovery in the Eagle Ford/Austin Chalk in South Texas.
CHKDJ CKRGZ CHKDP CHK CHKVP CHK.WI CHKDH CHKVZ CHK.PRD CHKDG CHKWZ

41
EIA Reports Above-Average Natural Gas Build, Price Falls

2018-07-09 zacks
The Weekly Natural Gas Storage Report – brought out by the Energy Information Administration (EIA) every Thursday since 2002 – includes updates on natural gas market prices, the latest storage level estimates, recent weather data and other market activities or events.
ECR CKRGZ CQP LNG CHKVP CRK COG CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI GPOR CHK.PRD

29
Why Chesapeake Energy (CHK) Stock Might be a Great Pick

2018-07-09 zacks
One stock that might be an intriguing choice for investors right now is Chesapeake Energy Corporation (CHK - Free Report) . This is because this security in the Oil and Gas - Exploration and Production - United States space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board.
CKRGZ CHKVP CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI CVRR CHK.PRD FSLR

77
CNX to Lower Debts, Buy Back Shares With Asset Sale Proceeds

2018-07-02 zacks
CNX Resources Corporation (CNX - Free Report) announced that it has entered in an agreement with Ascent Resources-Utica, LLC to sell its 50% interest in Ohio Utica joint venture (JV) assets to the latter for $400 million. CNX Resources’ Utica shale JV was formed with Hess Corporation (HES - Free Report) and the latter, in a separate agreement, decided to sell its 50% interest in the JV to Ascent Resources for $400 million.
CKRGZ CNX.WI HES CHKVP CHKDH CHKVZ ACTPF CHKDG CHKWZ HES.PRA CHKDJ CHKDP CHK CHK.WI AST CHK.PRD

1012
Weekly Commentary: A Decisive Quarter

2018-06-30 seekingalpha
June 29 - Financial Times (Peter Wells): "The buck is back. Tighter domestic monetary policy and global trade turmoil have set the US dollar for its best quarterly performance since December 2016. The DXY index, which tracks the US currency against a weighted basket of global peers, was up 5.2% in the three months to June 29. That has been achieved via a three-month winning streak, its first such run since December 2016, too.
BBDO CHKVP UAA MS.PRE MS.PRF MS.PRG CHKVZ MS.PRA SCGLF TWTR MS CHK.PRD CICHF CCB SCGLY TYT BDORY CMG BBD VLKAF NDAQ MS.PRI CHK MS.PRK 7203 SFUN GLE FB DB TIF HES TM NFLX AMD CBQS CHKDH CHKDG FMCKI FMCKJ CHKDJ KR ESV CHKDP ACA 0939 CKRGZ FMCCO FMCCP HYUO FMCCM FMCCN 55BC TRIP FMCCI ITUB FMCCJ M FMCCG FMCKO NYTAB FMCKP FMCKM CRARF TOYOF FMCKN FMCKK HYUD FMCKL CHKWZ DO CICHY UA ING OAS FMCC CHK.WI TSLA HYUP CRARY FMCCS FMCCT

75
Chesapeake's Completions Designs Are Reinventing The Company

2018-06-29 seekingalpha
A breakthrough in completions designs for Chesapeake Energy could mark a key turning point for the company. Designs have had a substantial impact on production, and seem repeatable in the future.
CHKDJ CKRGZ CHKDP CHK CHKVP CHK.WI CHKDH CHKVZ CHK.PRD CHKDG CHKWZ EOG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 165167784